FindTrial
Sign In

Pharmacokinetics and individualized dosing regimens of vancomycin in patients with severe infection

Pharmacokinetics and individualized dosing regimens of vancomycin in patients with severe infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015596
Enrollment
Unknown
Registered
2018-04-11
Start date
2015-01-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe infection

Interventions

simple severe infection group:vancomycin
renal failure group:vancomycin

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. a variety of G+ - infected patients were cultured; 2. bacteriological smears suggest staphylococcal infection; 3. the chief physician highly suspected G+ infection and experienced medication.

Exclusion criteria

Exclusion criteria: 1. allergic to glycopeptide antibiotics; 2. there is a hearing loss; 3. pregnant women or perinatal women; 4. patients with severe renal insufficiency.

Design outcomes

Primary

MeasureTime frame
Vancomycin Valley concentration;—

Countries

China

Contacts

Public ContactQi Zou

Intensive medicine department, The First Affiliated Hospital of Bengbu Medical College

panzersas@163.com+86 18955246090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026